BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34407748)

  • 21. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT).
    Diamond IR; Fecteau A; Millis JM; Losanoff JE; Ng V; Anand R; Song C;
    Ann Surg; 2007 Aug; 246(2):301-10. PubMed ID: 17667510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Hogen R; Lo M; DiNorcia J; Ji L; Genyk Y; Sher L; Dhanireddy K
    Transplantation; 2019 Apr; 103(4):747-754. PubMed ID: 29672442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.
    Mogul DB; Luo X; Garonzik-Wang J; Bowring MG; Massie AB; Schwarz KB; Cameron AM; Bridges JFP; Segev DL
    Liver Transpl; 2019 Jan; 25(1):119-127. PubMed ID: 30230191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Analysis of Donor Liver Allograft Outcomes in Hepatocellular Carcinoma Patients Who Underwent Liver Transplant.
    Al-Ameri AAM; Zhou Z; Zheng S
    Exp Clin Transplant; 2023 Aug; 21(8):664-670. PubMed ID: 37698401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.
    Renz JF; Kin C; Kinkhabwala M; Jan D; Varadarajan R; Goldstein M; Brown R; Emond JC
    Ann Surg; 2005 Oct; 242(4):556-63; discussion 563-5. PubMed ID: 16192816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variant techniques for liver transplantation in pediatric programs.
    Burgos L; Hernández F; Barrena S; Andres AM; Encinas JL; Leal N; Gamez M; Murcia J; Jara P; Lopez-Santamaria M; Tovar JA
    Eur J Pediatr Surg; 2008 Dec; 18(6):372-4. PubMed ID: 19039737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
    Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
    Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-liver transplant survival in hepatitis C patients is improving over time.
    O'Leary JG; Randall H; Onaca N; Jennings L; Klintmalm GB; Davis GL
    Liver Transpl; 2009 Apr; 15(4):360-8. PubMed ID: 19326409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?
    Rochon C; Sheiner P; Mahadevappa B; Gunasekaran G; Sharma J; Wolf DC; Facciuto M
    Langenbecks Arch Surg; 2012 Jun; 397(5):711-5. PubMed ID: 22282322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waitlist mortality and post-liver transplant outcomes of pediatric patients with hepatocellular carcinoma and hepatoblastoma in the United States.
    Wu WK; Ziogas IA; Matsuoka LK; Izzy M; Pai AK; Benedetti DJ; Alexopoulos SP
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29425. PubMed ID: 34736292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
    Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
    Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
    Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.